Article
Targeted disruption of the mouse ferrochelatase gene producing an exon 10 deletion.
Biochimica et biophysica acta - 6 Jan 1999
Magness S T, Brenner D A
Abstract excerpt
Protoporphyria is a disease characterized by a deficiency in ferrochelatase, the terminal enzyme in the heme biosynthetic pathway, which catalyzes the chelation of iron and protoporphyrin to form heme. Clinical symptoms arise from an accumulation of protoporphyrin behind the partial enzyme block and include photosensitivity and sometimes hepatobiliary disease. Protoporphyria is described as an dominant disease,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
